A primary focus during the early stages of research and drug development is to minimize future risk. As such, protein binding studies are often necessary to determine a drug’s efficacy. While regulatory guidance exists concerning protein-binding studies, detailed guidelines on how to perform and validate the procedures does not. This is where Worldwide shines and can play a vital role in your drug development program.
Worldwide’s wealth of experience executing protein-binding studies coupled with the application of larger capacity, automated formats delivers high-quality, timely data at excellent value. We can accommodate both in vitro and ex vivo protein-binding studies (from animal species to man) utilizing plasma or tissue homogenates. Our procedures include the following:
Are you ready to take your protein-binding study to the next level? Are you looking for a partner that can provide you with the operational excellence your program needs? Contact a Worldwide expert for support – no matter where you are on the path of drug development and research.
Make informed decisions, faster with Worldwide Clinical Trials’ Bioanalytical Laboratory